SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-045972
Filing Date
2013-08-14
Accepted
2013-08-14 17:53:51
Documents
10
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT v351920_10q.htm 10-Q 333677
2 CERTIFICATION v351920_ex31-1.htm EX-31.1 12479
3 CERTIFICATION v351920_ex31-2.htm EX-31.2 12406
4 CERTIFICATION v351920_ex32-1.htm EX-32.1 4480
  Complete submission text file 0001144204-13-045972.txt   5994359

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT iliu-20130630.xml EX-101.INS 506304
6 XBRL TAXONOMY EXTENSION SCHEMA iliu-20130630.xsd EX-101.SCH 46394
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE iliu-20130630_cal.xml EX-101.CAL 34193
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE iliu-20130630_def.xml EX-101.DEF 245863
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE iliu-20130630_lab.xml EX-101.LAB 319977
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iliu-20130630_pre.xml EX-101.PRE 285586
Mailing Address 135 BEAVER ST WATHAM MA 02452
Business Address 135 BEAVER ST WATHAM MA 02452 1-781-398-0700
INTERLEUKIN GENETICS INC (Filer) CIK: 0001037649 (see all company filings)

IRS No.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32715 | Film No.: 131039219
SIC: 2835 In Vitro & In Vivo Diagnostic Substances